Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Uvalysat Cranberry NEM
- Development stage
- Unknown
- Lead developer
- Johannes Bürger YS Lab
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Uvalysat Cranberry NEM is a multi-ingredient dietary supplement developed by Johannes Bürger Ysatfabrik GmbH (Ysat Bürger) to support urinary tract and bladder health. Each oral capsule contains 300 mg of cranberry extract, standardized to provide 18 mg of proanthocyanidins (PAC), and is supplemented with Vitamin C (48 mg) and Vitamin B3 (Niacin, 8 mg). The product is designed to reduce the risk of urinary tract infections through an anti-adhesive mechanism, where proanthocyanidins inhibit the attachment of bacteria, such as *Escherichia coli*, to the bladder epithelium. Additionally, Vitamin C and Vitamin B3 are included to support normal immune system function and the maintenance of healthy mucous membranes. The formulation is vegan, gluten-free, and lactose-free.
- Brand names
- Uvalysat Cranberry NEMUvalysat Cranberry
- Other names
- Uvalysat® CranberryCranberry supplement
02
Targets
P fimbriae
Beyond the preview
Go deeper on Uvalysat Cranberry NEM.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Uvalysat Cranberry NEM.